A blood clotting disorder is any condition that disrupts the normal balance of clot formation in your body. Some disorders cause your blood to clot too easily, leading to dangerous blockages in veins or arteries. Others, like hemophilia, prevent your blood from clotting properly, causing excessive bleeding. Roughly 100 out of every 100,000 people in the United States experience a clot-related event for the first time each year, and that number climbs sharply with age, reaching about 500 per 100,000 by age 80.
Two Opposite Problems
Blood clotting disorders fall into two broad categories that work in opposite directions. Thrombophilia means your blood clots more readily than it should. Clots can form inside a blood vessel and block blood flow to your organs, limbs, or lungs. On the other side, bleeding disorders like hemophilia mean your blood can’t form clots effectively, so cuts take too long to stop bleeding, and internal bleeding can occur with little or no injury.
Most people searching this term are dealing with (or worried about) the clotting-too-much side, so that’s where most of the practical detail below is focused. But if you bruise easily, bleed heavily from minor wounds, or have unusually long periods, a bleeding disorder may be the relevant concern.
Inherited Causes
The most common inherited clotting disorder is Factor V Leiden, a genetic mutation that affects a protein your body uses to regulate clot size. Normally, a built-in safety mechanism called activated protein C shuts down that clotting protein once a clot has done its job. In people with Factor V Leiden, the protein resists being shut down, so the clotting process stays active longer than it should and clots can grow larger than necessary.
Between 3 and 8 percent of people with European ancestry carry one copy of this mutation, making it surprisingly common. About 1 in 5,000 carry two copies, which increases risk more significantly. The mutation is less common in other ethnic groups. Other inherited causes include prothrombin gene mutations, and deficiencies in proteins C, S, or antithrombin, all of which normally act as brakes on your clotting system.
Carrying one of these genetic mutations doesn’t guarantee you’ll develop a clot. Many people live their entire lives without one. But the mutation raises your baseline risk, and when combined with other triggers (surgery, long immobility, pregnancy, or estrogen-containing medications), the odds can tip.
Acquired Causes
Not all clotting disorders are inherited. Antiphospholipid syndrome (APS) is an autoimmune condition where the immune system produces antibodies that interfere with normal blood clotting regulation. It’s diagnosed when someone has both a clotting event (or specific pregnancy complications) and blood tests that detect these antibodies on at least two occasions, 12 or more weeks apart. That waiting period matters because temporary antibody spikes can happen during infections and don’t necessarily indicate a lasting disorder.
APS is a significant cause of recurrent miscarriage. The diagnostic criteria specifically include unexplained fetal loss at or beyond 10 weeks, premature birth before 34 weeks due to complications like preeclampsia, or three or more consecutive early miscarriages before 10 weeks. If you’ve experienced repeated pregnancy losses, this is one of the conditions your doctor may screen for.
Hormones and Other Risk Factors
Estrogen increases clotting risk, which is why hormonal contraceptives and hormone replacement therapy are relevant for anyone with an underlying clotting tendency. Combined oral contraceptives roughly double to quadruple the risk of a venous clot depending on the specific formulation and dose. The Women’s Health Initiative trial found that hormone replacement therapy doubled the risk of venous clot events, with a hazard ratio of 2.06.
To put this in perspective, the baseline risk of a clot for a young, healthy woman is very low, so doubling a small number still gives a small number. But if you also carry a genetic mutation like Factor V Leiden, these risks multiply rather than simply add up. Other acquired risk factors include major surgery, cancer, prolonged bed rest, obesity, smoking, and long periods of immobility like extended travel.
What a Blood Clot Feels Like
The most common dangerous clot is a deep vein thrombosis (DVT), typically forming in the leg. The classic signs are swelling in one leg (not both), pain or tenderness that may feel like a cramp, warmth in the affected area, and skin that looks red or discolored. These symptoms usually develop in one limb, which helps distinguish a clot from general leg aches or muscle soreness.
The real danger comes when part of a DVT breaks loose and travels to the lungs, causing a pulmonary embolism. About 33% of people with a pulmonary embolism die before they receive a diagnosis and treatment, which is why recognizing the symptoms matters. The first signs are typically sudden shortness of breath and chest pain that worsens when you breathe deeply or exert yourself. You might also experience fast breathing, wheezing, a cough (sometimes with bloody mucus), or unexplained sharp pain in the chest, arm, shoulder, or jaw. These symptoms require emergency care immediately.
How Clotting Disorders Are Diagnosed
Diagnosis usually starts with blood tests that measure how quickly your blood forms clots. Prothrombin time (PT) normally falls between 9 and 13 seconds, while partial thromboplastin time (PTT) ranges from 25 to 35 seconds. Results outside these ranges point your doctor toward specific parts of the clotting system that may not be working correctly. A prolonged PT can suggest liver disease, vitamin K deficiency, or issues with certain clotting factors. A prolonged PTT may signal hemophilia or other factor deficiencies.
If a clotting-too-much disorder is suspected, additional tests look for specific causes: genetic testing for Factor V Leiden or prothrombin mutations, and blood tests for the antibodies associated with antiphospholipid syndrome. Testing is most often recommended after an unexplained clot (especially in someone under 50), clots in unusual locations, recurrent clots, or a strong family history of clotting events.
Treatment and Daily Management
Blood thinners (anticoagulants) are the cornerstone of treatment for clotting disorders. Older options like warfarin require regular blood monitoring and careful dietary management because vitamin K intake affects how the drug works. Newer direct oral anticoagulants have simplified treatment for many people, requiring less monitoring and fewer food restrictions. Your doctor chooses between these based on the specific disorder, your kidney function, and other medications you take.
How long you stay on blood thinners depends on the situation. A first clot triggered by a clear, temporary cause (like surgery) might require only three to six months of treatment. A clot linked to an inherited disorder or APS, or a second unprovoked clot, often means long-term or lifelong anticoagulation. Living on blood thinners means being more cautious about activities with a high risk of injury and being aware that cuts and bruises will take longer to resolve.
Reducing Your Risk During Travel
Flights and long car rides lasting four hours or more increase clot risk because of prolonged sitting. Compression stockings are the most studied preventive measure for travelers. Clinical trials have tested stockings providing 10 to 30 mmHg of pressure at the ankle, with both ranges showing benefit. For most people at moderate risk, knee-high graduated compression stockings in the 15 to 30 mmHg range are a practical choice.
Beyond compression, moving your legs regularly during travel helps. Flexing your ankles, walking the aisle when possible, and staying hydrated all support blood flow. If you have a known clotting disorder and are planning a long trip, your doctor may recommend a preventive dose of blood thinner before and after travel, particularly for flights exceeding five hours.
Who Gets Tested and Why It Matters
Clotting disorders are more common in some populations than others. Among predominantly Caucasian populations, first-time clot incidence ranges from 71 to 117 per 100,000 people per year. The rates differ significantly by ethnicity: about 93 per 100,000 among African Americans, 37 per 100,000 among Latinos, and 19 per 100,000 among Asian-Pacific Islanders. These differences likely reflect a combination of genetic prevalence (Factor V Leiden is most common in European populations) and other risk factors.
Testing is most valuable when results would change what you do. If you’ve had an unexplained clot, knowing the cause helps determine how long to stay on treatment. If a close relative had a clotting disorder and you’re planning surgery, pregnancy, or starting hormonal contraception, knowing your status lets you and your doctor take precautions. Routine screening in people without symptoms or risk factors generally isn’t recommended because carrying a mutation doesn’t mean a clot is inevitable, and the anxiety of a positive result can outweigh the benefit when the absolute risk remains low.